About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma ...

The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release ...

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...

Supreme Group has consolidated two of the companies it bought during a nine-deal, 18-month splurge, combining Amendola ...

After pressure from the FTC, Teva has asked the FDA to delist hundreds of patents on products for asthma, diabetes, chronic obstructive pulmonary disease and for epinephrine autoinjectors, the agency ...

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. | Pfizer has rolled out detailed trial ...

Three-quarters of those surveyed said the program’s resources helped reduce unwanted physical side effects, and more than 80% said it lessened at least one aspect of financial stress. Overall, 85% ...

The U.K. is upholding its end of a recent trade deal with the U.S., increasing the island country’s potential spending on new medicines by cutting the rebates paid by pharma companies under a ...

The new Lilly facilities—which include a $5 billion API plant near Richmond, Virginia, which was announced in September—are ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem cell-based therapy to treat severe aplastic ...

A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that ...